Cargando…
Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma
BACKGROUND: We aimed to identify the relationship between thyroid transcription factor‐1 (TTF‐1) expression of lung adenocarcinoma and the efficacy of immune‐checkpoint inhibitor (ICI) therapy. METHODS: This retrospective multicenter study comprised patients with advanced lung adenocarcinoma treated...
Autores principales: | Nakahama, Kenji, Kaneda, Hiroyasu, Osawa, Masahiko, Izumi, Motohiro, Yoshimoto, Naoki, Sugimoto, Akira, Nagamine, Hiroaki, Ogawa, Koichi, Matsumoto, Yoshiya, Sawa, Kenji, Tani, Yoko, Mitsuoka, Shigeki, Watanabe, Tetsuya, Asai, Kazuhisa, Kawaguchi, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376174/ https://www.ncbi.nlm.nih.gov/pubmed/35808895 http://dx.doi.org/10.1111/1759-7714.14560 |
Ejemplares similares
-
SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3
por: Nakahama, Kenji, et al.
Publicado: (2022) -
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
por: Nakahama, Kenji, et al.
Publicado: (2022) -
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian)
por: Izumi, Motohiro, et al.
Publicado: (2020) -
Safe Concurrent Use of Anti-tuberculosis Drugs and Pembrolizumab in a Patient with Non-small-cell Lung Cancer Who Was Infected with Mycobacterium tuberculosis
por: Nakahama, Kenji, et al.
Publicado: (2022) -
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors
por: Izumi, Motohiro, et al.
Publicado: (2021)